WHO ICTRP trial
A single-center, prospective, self-controlled study of recombinat human…
ChiCTR2100049137 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2100049137 |
|---|---|
| Public title | A single-center, prospective, self-controlled study of recombinat human thrombopoietin in the treatment of thrombocytopenia following high dose cytarabine consolidation chemotherapy in acute myeloid leukemia |
| Scientific title | A single-center, prospective, self-controlled study of recombinat human thrombopoietin in the treatment of thrombocytopenia following high dose cytarabine consolidation chemotherapy in acute myeloid leukemia |
| Primary sponsor | First Affiliated Hospital, College of Medcine, Zhejiang University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 3 |
| Countries | China |
| Conditions | Acute myeloid leukemia |
| Interventions | Control group:None;Experimental group:rhTHP treatment after chemotherapy |
| Registration date | Jul 22, 2021 |
| Target size | Control group:29;Experimental group:29 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: